vs
MKS INC（MKSI）与MESA LABORATORIES INC（MLAB）财务数据对比。点击上方公司名可切换其他公司
MKS INC的季度营收约是MESA LABORATORIES INC的15.9倍（$1.0B vs $65.1M）。MKS INC净利率更高（10.3% vs 5.6%，领先4.8%）。MKS INC同比增速更快（10.6% vs 3.6%）。MKS INC自由现金流更多（$92.0M vs $18.0M）。过去两年MKS INC的营收复合增速更高（9.1% vs 5.1%）
MKS Inc原是跨国独立软件供应商，业务覆盖应用生命周期管理（ALM）及系统管理两大领域，2011年5月31日被参数技术公司（PTC, Inc.）收购，目前为PTC旗下子公司。
梅萨实验室有限公司开发、生产和销售专业质控、校准及监测仪器与配套服务，核心业务覆盖医疗健康、制药、食品饮料、工业卫生及环境检测领域，为全球客户满足合规及运营安全需求提供支持。
MKSI vs MLAB — 直观对比
营收规模更大
MKSI
是对方的15.9倍
$65.1M
营收增速更快
MKSI
高出7.0%
3.6%
净利率更高
MKSI
高出4.8%
5.6%
自由现金流更多
MKSI
多$74.0M
$18.0M
两年增速更快
MKSI
近两年复合增速
5.1%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $65.1M |
| 净利润 | $107.0M | $3.6M |
| 毛利率 | 46.3% | 64.2% |
| 营业利润率 | 13.9% | 12.2% |
| 净利率 | 10.3% | 5.6% |
| 营收同比 | 10.6% | 3.6% |
| 净利润同比 | 18.9% | 316.6% |
| 每股收益（稀释后） | $1.58 | $0.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MKSIMLAB
| Q4 25 | $1.0B | $65.1M | ||
| Q3 25 | $988.0M | $60.7M | ||
| Q2 25 | $973.0M | $59.5M | ||
| Q1 25 | $936.0M | $62.1M | ||
| Q4 24 | $935.0M | $62.8M | ||
| Q3 24 | $896.0M | $57.8M | ||
| Q2 24 | $887.0M | $58.2M | ||
| Q1 24 | $868.0M | $58.9M |
净利润MKSIMLAB
| Q4 25 | $107.0M | $3.6M | ||
| Q3 25 | $74.0M | $2.5M | ||
| Q2 25 | $62.0M | $4.7M | ||
| Q1 25 | $52.0M | $-7.1M | ||
| Q4 24 | $90.0M | $-1.7M | ||
| Q3 24 | $62.0M | $3.4M | ||
| Q2 24 | $23.0M | $3.4M | ||
| Q1 24 | $15.0M | $-254.6M |
毛利率MKSIMLAB
| Q4 25 | 46.3% | 64.2% | ||
| Q3 25 | 46.7% | 61.5% | ||
| Q2 25 | 46.6% | 62.0% | ||
| Q1 25 | 47.4% | 61.8% | ||
| Q4 24 | 47.3% | 63.3% | ||
| Q3 24 | 48.2% | 61.3% | ||
| Q2 24 | 47.2% | 64.0% | ||
| Q1 24 | 47.8% | 62.1% |
营业利润率MKSIMLAB
| Q4 25 | 13.9% | 12.2% | ||
| Q3 25 | 14.0% | 7.8% | ||
| Q2 25 | 13.9% | 5.1% | ||
| Q1 25 | 11.9% | 2.4% | ||
| Q4 24 | 14.7% | 9.2% | ||
| Q3 24 | 14.3% | 6.1% | ||
| Q2 24 | 14.3% | 9.6% | ||
| Q1 24 | 12.2% | -460.6% |
净利率MKSIMLAB
| Q4 25 | 10.3% | 5.6% | ||
| Q3 25 | 7.5% | 4.1% | ||
| Q2 25 | 6.4% | 8.0% | ||
| Q1 25 | 5.6% | -11.4% | ||
| Q4 24 | 9.6% | -2.7% | ||
| Q3 24 | 6.9% | 5.9% | ||
| Q2 24 | 2.6% | 5.8% | ||
| Q1 24 | 1.7% | -432.2% |
每股收益（稀释后）MKSIMLAB
| Q4 25 | $1.58 | $0.65 | ||
| Q3 25 | $1.10 | $0.45 | ||
| Q2 25 | $0.92 | $0.85 | ||
| Q1 25 | $0.77 | $-1.30 | ||
| Q4 24 | $1.34 | $-0.31 | ||
| Q3 24 | $0.92 | $0.63 | ||
| Q2 24 | $0.33 | $0.62 | ||
| Q1 24 | $0.22 | $-47.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $418.0M | $29.0M |
| 总债务越低越好 | $4.2B | $68.4M |
| 股东权益账面价值 | $2.7B | $186.7M |
| 总资产 | $8.8B | $434.8M |
| 负债/权益比越低杠杆越低 | 1.53× | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资MKSIMLAB
| Q4 25 | $418.0M | $29.0M | ||
| Q3 25 | $413.0M | $20.4M | ||
| Q2 25 | $498.0M | $21.3M | ||
| Q1 25 | $407.0M | $27.3M | ||
| Q4 24 | $420.0M | $27.3M | ||
| Q3 24 | $439.0M | $24.3M | ||
| Q2 24 | $506.0M | $28.5M | ||
| Q1 24 | $1.0M | $28.2M |
总债务MKSIMLAB
| Q4 25 | $4.2B | $68.4M | ||
| Q3 25 | $4.3B | $69.4M | ||
| Q2 25 | $4.4B | $70.3M | ||
| Q1 25 | $4.4B | $71.3M | ||
| Q4 24 | $4.5B | $72.2M | ||
| Q3 24 | $4.8B | $73.1M | ||
| Q2 24 | $4.8B | $74.1M | ||
| Q1 24 | $4.7B | — |
股东权益MKSIMLAB
| Q4 25 | $2.7B | $186.7M | ||
| Q3 25 | $2.6B | $178.5M | ||
| Q2 25 | $2.6B | $172.5M | ||
| Q1 25 | $2.4B | $159.8M | ||
| Q4 24 | $2.3B | $155.2M | ||
| Q3 24 | $2.4B | $161.5M | ||
| Q2 24 | $2.2B | $150.7M | ||
| Q1 24 | $2.4B | $145.4M |
总资产MKSIMLAB
| Q4 25 | $8.8B | $434.8M | ||
| Q3 25 | $8.8B | $430.4M | ||
| Q2 25 | $8.8B | $435.7M | ||
| Q1 25 | $8.6B | $433.3M | ||
| Q4 24 | $8.6B | $433.3M | ||
| Q3 24 | $9.0B | $454.1M | ||
| Q2 24 | $8.9B | $440.4M | ||
| Q1 24 | $8.9B | $446.8M |
负债/权益比MKSIMLAB
| Q4 25 | 1.53× | 0.37× | ||
| Q3 25 | 1.64× | 0.39× | ||
| Q2 25 | 1.71× | 0.41× | ||
| Q1 25 | 1.87× | 0.45× | ||
| Q4 24 | 1.93× | 0.47× | ||
| Q3 24 | 1.98× | 0.45× | ||
| Q2 24 | 2.16× | 0.49× | ||
| Q1 24 | 1.94× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $142.0M | $18.8M |
| 自由现金流经营现金流 - 资本支出 | $92.0M | $18.0M |
| 自由现金流率自由现金流/营收 | 8.9% | 27.7% |
| 资本支出强度资本支出/营收 | 4.8% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.33× | 5.17× |
| 过去12个月自由现金流最近4个季度 | $497.0M | $37.9M |
8季度趋势，按日历期对齐
经营现金流MKSIMLAB
| Q4 25 | $142.0M | $18.8M | ||
| Q3 25 | $197.0M | $8.2M | ||
| Q2 25 | $165.0M | $1.9M | ||
| Q1 25 | $141.0M | $12.7M | ||
| Q4 24 | $176.0M | $18.1M | ||
| Q3 24 | $163.0M | $5.3M | ||
| Q2 24 | $122.0M | $10.7M | ||
| Q1 24 | $67.0M | $12.9M |
自由现金流MKSIMLAB
| Q4 25 | $92.0M | $18.0M | ||
| Q3 25 | $146.0M | $7.1M | ||
| Q2 25 | $136.0M | $884.0K | ||
| Q1 25 | $123.0M | $11.9M | ||
| Q4 24 | $125.0M | $17.3M | ||
| Q3 24 | $141.0M | $3.5M | ||
| Q2 24 | $95.0M | $9.9M | ||
| Q1 24 | $49.0M | $12.3M |
自由现金流率MKSIMLAB
| Q4 25 | 8.9% | 27.7% | ||
| Q3 25 | 14.8% | 11.7% | ||
| Q2 25 | 14.0% | 1.5% | ||
| Q1 25 | 13.1% | 19.2% | ||
| Q4 24 | 13.4% | 27.6% | ||
| Q3 24 | 15.7% | 6.0% | ||
| Q2 24 | 10.7% | 16.9% | ||
| Q1 24 | 5.6% | 21.0% |
资本支出强度MKSIMLAB
| Q4 25 | 4.8% | 1.1% | ||
| Q3 25 | 5.2% | 1.8% | ||
| Q2 25 | 3.0% | 1.7% | ||
| Q1 25 | 1.9% | 1.2% | ||
| Q4 24 | 5.5% | 1.3% | ||
| Q3 24 | 2.5% | 3.1% | ||
| Q2 24 | 3.0% | 1.5% | ||
| Q1 24 | 2.1% | 0.9% |
现金转化率MKSIMLAB
| Q4 25 | 1.33× | 5.17× | ||
| Q3 25 | 2.66× | 3.32× | ||
| Q2 25 | 2.66× | 0.40× | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 2.63× | 1.54× | ||
| Q2 24 | 5.30× | 3.17× | ||
| Q1 24 | 4.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MKSI
| Electronics And Packaging | $303.0M | 29% |
| Specialty Industrial | $295.0M | 29% |
| Photonics Solutions Division | $274.0M | 26% |
| Services | $125.0M | 12% |
| Other | $37.0M | 4% |
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
